Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v8-EN
Language English English
Date Updated 2018-04-20 2018-04-20
Drug Identification Number 02183080 02183080
Brand name PENTAMIDINE ISETIONATE FOR INJECTION BP PENTAMIDINE ISETIONATE FOR INJECTION BP
Common or Proper name PENTAMIDINE ISETIONATE PENTAMIDINE ISETIONATE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients PENTAMIDINE ISETIONATE PENTAMIDINE ISETIONATE
Strength(s) 300MG 300MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 5 x 300mg GVL 5 x 300mg GVL
ATC code P01CX P01CX
ATC description AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-03-26 2018-03-26
Actual start date
Estimated end date
Actual end date 2018-04-19 2018-04-19
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments